著者
Sosho KAJIWARA Yu HASEGAWA Tetsuya NEGOTO Kimihiko ORITO Takayuki KAWANO Munetake YOSHITOMI Kiyohiko SAKATA Nobuyuki TAKESHIGE Yukako YAMAKAWA Hirofumi JONO Hideyuki SAITO Nobuhisa HIRAYU Osamu TAKASU Masaru HIROHATA Motohiro MORIOKA
出版者
The Japan Neurosurgical Society
雑誌
Neurologia medico-chirurgica (ISSN:04708105)
巻号頁・発行日
vol.61, no.9, pp.528-535, 2021 (Released:2021-09-15)
参考文献数
21
被引用文献数
3

This study aimed to examine the beneficial effects of a novel prophylactic barbiturate therapy, step-down infusion of barbiturates, using thiamylal with normothermia (NOR+sdB), on the poor outcome in the patients with severe traumatic brain injuries (sTBI), in comparison with mild hypothermia (MD-HYPO). From January 2000 to March 2019, 4133 patients with TBI were admitted to our hospital. The inclusion criteria were: a Glasgow coma scale (GCS) score of ≤8 on admission, age between 20 and 80 years, intracranial hematoma requiring surgical evacuation of the hematoma with craniotomy and/or external decompression, and patients who underwent management of body temperature and assessed their outcome at 6–12 months. Finally, 43 patients were included in the MD-HYPO (n = 29) and NOR+sdB (n = 14) groups. sdB was initiated intraoperatively or immediately after the surgical treatment. There were no significant differences in patient characteristics, including age, sex, past medical history, GCS on admission, type of intracranial hematoma, and length of hospitalization between the two groups. Although NOR+sdB could not improve the patient’s poor outcome either at discharge from the intensive care unit (ICU) or at 6–12 months after admission, the treatment inhibited composite death at discharge from the ICU. The mean value of the maximum intracranial pressure (ICP) in the NOR+sdB group was <20 mmHg throughout the first 120 h. NOR+sdB prevented composite death in the ICU in patients with sTBI, and we may obtain novel insights into the beneficial role of prophylactic barbiturate therapy from suppression of the elevated ICP during the first 120 h.

言及状況

外部データベース (DOI)

Twitter (2 users, 2 posts, 0 favorites)

A study for the efficacy of prophylactic barbiturate therapy for severe TBI Barbiturate used 3.0mg/kg/h 0-24h 2.0mg/kg/h 24-48h 1.5mg/kg/h 48-72h 1.0mg/kg/h 72-96h Mortality and the time of discharge from the ICU was significantly reduced. #neurosurgery https://t.co/bkzxKKiiJv
重症頭部外傷後にバルビツレートの段階的投与が有効という論文 GCS8以下、開頭手術、体温管理をした43人の後方視研究 3.0mg/kg/h 0-24h 2.0mg/kg/h 24-48h 1.5mg/kg/h 48-72h とバルビツレートを投与 合併症率を上げず、死亡率とICU退室までの期間を有意に短縮 #脳外科 https://t.co/VBTTHAasCU

収集済み URL リスト